The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy
The Racial Rules of Corporate Power: How Extractive Corporate Power Harms Black and Brown Communities and How Race-Conscious Solutions Can Create an Inclusive Economy
November 25, 2019
New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
October 28, 2019
Testimony before the House Financial Services Committee Subcommittee on Investor Protection, Entrepreneurship, and Capital Markets
Testimony before the House Financial Services Committee Subcommittee on Investor Protection, Entrepreneurship, and Capital Markets
October 15, 2019
Stock Buybacks Are a Key Example of Extractive Corporate Power
Stock Buybacks Are a Key Example of Extractive Corporate Power
October 15, 2019
21st Century Corporate Governance: New Rules for Worker Representation on Corporate Boards
21st Century Corporate Governance: New Rules for Worker Representation on Corporate Boards
September 27, 2019
Toward Sustainable, Equitable Trade Policy—Not False Solutions
Toward Sustainable, Equitable Trade Policy—Not False Solutions
September 9, 2019
Do Corporate Insiders Use Stock Buybacks for Personal Gain?
Do Corporate Insiders Use Stock Buybacks for Personal Gain?
July 2, 2019
Profit Over Patients: Americans are Paying for a Financialized Pharmaceutical Industry
Profit Over Patients: Americans are Paying for a Financialized Pharmaceutical Industry
June 19, 2019
The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients
The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients
May 22, 2019